Poxel’s Phase II Data Add AMP Kinase Activation To NASH Possibilities

 
• By Joseph Haas
  
businessman chooses the path strategy
Add AMPK activation to the mechanisms of action now in mid-stage NASH development
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D